[Asia Economy Reporter Yoo Byung-don] Solgo Bio announced on the 28th that it has decided to issue the 11th series of unnamed subordinated unsecured convertible bonds (CB) worth 3 billion KRW. The purpose of issuing the convertible bonds is to raise operating funds.
The nominal interest rate and maturity interest rate are 3% and 5%, respectively. The conversion price is 500 KRW, and the conversion ratio is 100%. The bond maturity date is April 28, 2024.
The conversion target is Solgo Biomedical registered common shares, totaling 6 million shares. The conversion request period is from April 28, 2022, to March 28, 2024.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
